Alternate Name(s) |
(2R,4S,5R)-2-Biphenyl-3-ylmethyl-3,4-dimethyl-5-phenyl-[1,3,2]oxazaphospholidine 2-oxide
(2S,4S,5R)-3,4-dimethyl-5-phenyl-2-(3-phenylbenzyl)-1,3,2-oxazaphospholidine 2-oxide
(2S,4S,5R)-3,4-dimethyl-5-phenyl-2-[(3-phenylphenyl)methyl]-1,3,2-oxazaphospholidine 2-oxide
(4S,5R)-2-([1,1'-biphenyl]-3-ylmethyl)-3,4-dimethyl-5-phenyl-1,3,2-oxazaphospholidine 2-oxide
cis-(2R,4S,5R)-2-(m-Phenylbenzyl)-3,4-dimethyl-2-oxo-5-phenyl-1,3,2.lambda.5-oxazaphospholidine
trans-(2R,4S,5R)-2-(m-Phenylbenzyl)-3,4-dimethyl-2-oxo-5-phenyl-1,3,2.lambda.5-oxazaphospholidine
(2S,4S,5R)-3,4-dimethyl-5-phenyl-2-[(3-phenylphenyl)methyl]-1,3,2$l^{5}-oxazaphospholidine 2-oxide |
InChI |
InChI=1S/C23H24NO2P/c1-18-23(21-13-7-4-8-14-21)26-27(25,24(18)2)17-19-10-9-15-22(16-19)20-11-5-3-6-12-20/h3-16,18,23H,17H2,1-2H3/t18-,23-,27-/m0/s1 |